BookLeo J. McCarthy.
"Cryoprecipitate is still transfused although its genuine indications are specific and therefore, limited. Its accidental, yet fortuitous discovery by Dr. Judith Pool, and its clinical effectiveness subsequently established by Dr. Ed. Hershgold, enabled cryoprecipitate to quickly become the standard therapy for patients worldwide afflicted with hemophilia. However, its usage has declined since monoclonal factor VIII has emerged as the new standard of therapy primarily because of its lack of viral infectivity. Our expreience indicates it is frequently not transfused appropriately."--leaf 2.
Location
Version
Call Number
Items